Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7253493
Reference Type
Journal Article
Title
Clonidine decreases vasoconstriction and shivering thresholds, without affecting the sweating threshold
Author(s)
Nicolaou, G; Chen, AA; Johnston, CE; Kenny, GP; Bristow, GK; Giesbrecht, GG; ,
Year
1997
Is Peer Reviewed?
1
Journal
Canadian Journal of Anesthesia
ISSN:
0832-610X
EISSN:
1496-8975
Publisher
CANADIAN ANAESTHETISTS SOC INC
Location
TORONTO
Volume
44
Issue
6
Page Numbers
636-642
Language
English
PMID
9187784
DOI
10.1007/BF03015448
Web of Science Id
WOS:A1997XC86800011
Abstract
Purpose: This study was conducted to lest the hypothesis that clonidine produces a dose-dependent increase in the sweating threshold and dose-dependent decreases in vasoconstriction and shivering thresholds.Methods: Six healthy subjects (two female) were studied on four days after taking clonidine in oral doses of either 0 (control), 3, 6 or 9 mu g.kg(-1). The order followed a balanced design in a double-blind fashion, Oesophageal temperature and mean skin temperature (from 12 sites) were measured. Subjects were seated in 37 degrees C water which was gradually warmed until sweating occurred (sweat rate increased above 50 g.m(-2)h(-1)). The water was then cooled gradually until thresholds for vasoconstriction (onset of sustained decrease in fingertip blood flow! and shivering (sustained elevation in metabolism! were determined. Thresholds were then referred to as the core temperature, adjusted to a designated mean skin temperature of 33 degrees C.Results: High dose clonidine similarly decreased the adjusted core temperature thresholds for vasoconstriction by 1.16 +/- 0.30 degrees C and for shivering by 1.63 +/- 0.23 degrees C (P < 0.01), The dose response effects were linear for both cold responses with vasoconstriction and shivering thresholds decreasing by 0.13 +/- 0.05 and 0.19 +/- 0.09 degrees C.mu g(-1) respectively (P < 0.0001). The sweating threshold was unaffected by clonidine, however the interthreshold range between sweating and vasoconstriction thresholds increased from control (0.19 +/- 0.48 degrees C) to high dose clonidine (1.31 +/- 0.54 degrees C).Conclusion: The decreases in core temperature thresholds For cold responses and increased interthreshold range are consistent with the effects of several anaesthetic agents and opioids and is indicative of central thermoregulatory inhibition.
Tags
•
PFAS Universe
Data Source
Web of Science
Enflurane
Isoflurane
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity